Live Breaking News & Updates on Government medical college omandurar

Stay informed with the latest breaking news from Government medical college omandurar on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Government medical college omandurar and stay connected to the pulse of your community

Antiviral drug 'Clevira' repurposed for treatment of mild to moderate COVID-19 cases

Antiviral drug 'Clevira' repurposed for treatment of mild to moderate COVID-19 cases
Photo: Pexels
Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate COVID-19 cases, its manufacturer Apex Laboratories Private Limited said on Friday.
The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. The drug has also proved to be safe on liver and kidney parameters, it said.
"Clevira, an antiviral formulation, has received regulatory approval as a supportive treatment for mild to moderate COVID-19 cases," the Chennai-based pharmaceutical company said.

India , Chennai , Tamil-nadu , C-arthur-paul , International-business , Indian-council-for-medical-research , Apex-laboratories-private , Ayurvedic-sciences , Interdisciplinary-technical-review-committee , Central-council-for-research , Government-medical-college-omandurar , Apex-laboratories-private-limited

Antiviral drug 'Clevira' repurposed for treating mild to moderate Covid-19 patients | India News

India News: NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate Covid-19 cases, its m.

India , Chennai , Tamil-nadu , C-arthur-paul , International-business , Indian-council-for-medical-research , Apex-laboratories-private , Ayurvedic-sciences , Interdisciplinary-technical-review-committee , Central-council-for-research , Government-medical-college-omandurar , Apex-laboratories-private-limited

Antiviral drug Clevira repurposed for treating mild to moderate COVID-19 cases

New Delhi: Clevira, a drug primarily developed to treat dengue, has been repurposed as a supportive treatment for mild to moderate COVID-19 cases, its

India , New-delhi , Delhi , Chennai , Tamil-nadu , C-arthur-paul , International-business , Indian-council-for-medical-research , Apex-laboratories-private , Ayurvedic-sciences , Interdisciplinary-technical-review-committee , Central-council-for-research

Antiviral drug 'Clevira' repurposed for treating mild to moderate COVID-19 patients

Antiviral drug 'Clevira' repurposed for treating mild to moderate COVID-19 patients
The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days.
Share Via Email
| A+A A-
Beds lie inside an indoor stadium converted into COVID-19 treatment center for emergencies in the wake of the spike in the numbers of positive coronavirus cases in Srinagar. (Photo | AP)
By PTI
NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate COVID-19 cases, its manufacturer Apex Laboratories Private Limited said on Friday.
The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days.

India , Chennai , Tamil-nadu , C-arthur-paul , International-business , Indian-council-for-medical-research , Apex-laboratories-private , Ayurvedic-sciences , Interdisciplinary-technical-review-committee , Central-council-for-research , Government-medical-college-omandurar , Apex-laboratories-private-limited